#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Referent|entity|infstat
#T_RL=webanno.custom.Coref|type|BT_webanno.custom.Referent


#Text=4 .
1-1	0-1	4	quantity	new	_	_
1-2	2-3	.	_	_	_	_

#Text=Natural Antimicrobials from Bacteria and Viruses :
2-1	4-11	Natural	substance[2]	new[2]	_	_
2-2	12-26	Antimicrobials	substance[2]	new[2]	_	_
2-3	27-31	from	substance[2]	new[2]	_	_
2-4	32-40	Bacteria	substance[2]|substance|abstract[4]	new[2]|new|new[4]	coref|coref|coref|coref	7-7[16_0]|24-22[197_4]|7-7[16_0]|24-22[197_4]
2-5	41-44	and	substance[2]|abstract[4]	new[2]|new[4]	_	_
2-6	45-52	Viruses	substance[2]|abstract[4]|place	new[2]|new[4]|new	_	_
2-7	53-54	:	_	_	_	_

#Text=Biopreservation
3-1	55-70	Biopreservation	abstract	new	coref	4-1

#Text=Biopreservation is defined as “ the use of microorganisms ( including bacteriophages ) , their metabolic products , or both to preserve foods that are not generally considered fermented ” .
4-1	71-86	Biopreservation	abstract	giv	coref	8-6
4-2	87-89	is	_	_	_	_
4-3	90-97	defined	_	_	_	_
4-4	98-100	as	_	_	_	_
4-5	101-102	“	_	_	_	_
4-6	103-106	the	_	_	_	_
4-7	107-110	use	_	_	_	_
4-8	111-113	of	_	_	_	_
4-9	114-128	microorganisms	animal	new	ana	4-15
4-10	129-130	(	_	_	_	_
4-11	131-140	including	_	_	_	_
4-12	141-155	bacteriophages	substance	new	_	_
4-13	156-157	)	_	_	_	_
4-14	158-159	,	_	_	_	_
4-15	160-165	their	animal	giv	_	_
4-16	166-175	metabolic	_	_	_	_
4-17	176-184	products	_	_	_	_
4-18	185-186	,	_	_	_	_
4-19	187-189	or	_	_	_	_
4-20	190-194	both	_	_	_	_
4-21	195-197	to	_	_	_	_
4-22	198-206	preserve	_	_	_	_
4-23	207-212	foods	substance	new	coref	18-9
4-24	213-217	that	_	_	_	_
4-25	218-221	are	_	_	_	_
4-26	222-225	not	_	_	_	_
4-27	226-235	generally	_	_	_	_
4-28	236-246	considered	_	_	_	_
4-29	247-256	fermented	_	_	_	_
4-30	257-258	”	_	_	_	_
4-31	259-260	.	_	_	_	_

#Text=4.1 .
5-1	261-264	4.1	abstract	new	_	_
5-2	265-266	.	_	_	_	_

#Text=Controlled Acidification
6-1	267-277	Controlled	substance[13]	new[13]	coref	13-50[0_13]
6-2	278-291	Acidification	substance[13]	new[13]	_	_

#Text=The production of acid by lactic acid bacteria ( LAB ) under controlled acidification conditions is a preservation form very important in food production ; the pH of the food , the characteristics of the targeted microorganism , the fermented carbohydrate that is going to be used by the biopreservatives , the LAB growth kinetics , the temperature ( refrigeration or abuse ) , and the targeted pathogens are factors to be taken into account .
7-1	292-295	The	abstract[14]	new[14]	coref	7-17[21_14]
7-2	296-306	production	abstract[14]	new[14]	_	_
7-3	307-309	of	abstract[14]	new[14]	_	_
7-4	310-314	acid	abstract[14]|substance[15]	new[14]|new[15]	coref	8-39[0_15]
7-5	315-317	by	abstract[14]|substance[15]	new[14]|new[15]	_	_
7-6	318-324	lactic	abstract[14]|substance[15]	new[14]|new[15]	_	_
7-7	325-329	acid	abstract[14]|substance[15]|substance[16]	new[14]|new[15]|giv[16]	coref	13-1[88_16]
7-8	330-338	bacteria	abstract[14]|substance[15]|substance[16]	new[14]|new[15]|giv[16]	_	_
7-9	339-340	(	_	_	_	_
7-10	341-344	LAB	object	new	coref	7-53
7-11	345-346	)	_	_	_	_
7-12	347-352	under	_	_	_	_
7-13	353-363	controlled	abstract[19]	new[19]	coref	10-26[77_19]
7-14	364-377	acidification	abstract|abstract[19]	new|new[19]	_	_
7-15	378-388	conditions	abstract[19]	new[19]	_	_
7-16	389-391	is	_	_	_	_
7-17	392-393	a	abstract[21]	giv[21]	coref	7-23[23_21]
7-18	394-406	preservation	abstract|abstract[21]	new|giv[21]	_	_
7-19	407-411	form	abstract[21]	giv[21]	_	_
7-20	412-416	very	_	_	_	_
7-21	417-426	important	_	_	_	_
7-22	427-429	in	_	_	_	_
7-23	430-434	food	substance|abstract[23]	new|giv[23]	appos|coref|appos|coref	7-26[24_23]|7-29[25_0]|7-26[24_23]|7-29[25_0]
7-24	435-445	production	abstract[23]	giv[23]	_	_
7-25	446-447	;	_	_	_	_
7-26	448-451	the	abstract[24]	giv[24]	coref	8-27[0_24]
7-27	452-454	pH	abstract[24]	giv[24]	_	_
7-28	455-457	of	abstract[24]	giv[24]	_	_
7-29	458-461	the	abstract[24]|substance[25]	giv[24]|giv[25]	coref	8-36[50_25]
7-30	462-466	food	abstract[24]|substance[25]	giv[24]|giv[25]	_	_
7-31	467-468	,	abstract[24]	giv[24]	_	_
7-32	469-472	the	abstract[24]	giv[24]	_	_
7-33	473-488	characteristics	abstract[24]	giv[24]	_	_
7-34	489-491	of	abstract[24]	giv[24]	_	_
7-35	492-495	the	abstract[24]|object[26]	giv[24]|new[26]	_	_
7-36	496-504	targeted	abstract[24]|object[26]	giv[24]|new[26]	_	_
7-37	505-518	microorganism	abstract[24]|object[26]	giv[24]|new[26]	_	_
7-38	519-520	,	abstract[24]	giv[24]	_	_
7-39	521-524	the	abstract[24]|substance[27]	giv[24]|new[27]	coref	8-45[55_27]
7-40	525-534	fermented	abstract[24]|substance[27]	giv[24]|new[27]	_	_
7-41	535-547	carbohydrate	abstract[24]|substance[27]	giv[24]|new[27]	_	_
7-42	548-552	that	_	_	_	_
7-43	553-555	is	_	_	_	_
7-44	556-561	going	_	_	_	_
7-45	562-564	to	_	_	_	_
7-46	565-567	be	_	_	_	_
7-47	568-572	used	_	_	_	_
7-48	573-575	by	_	_	_	_
7-49	576-579	the	substance[28]	new[28]	_	_
7-50	580-596	biopreservatives	substance[28]	new[28]	_	_
7-51	597-598	,	_	_	_	_
7-52	599-602	the	abstract[31]	new[31]	_	_
7-53	603-606	LAB	object|abstract[31]	giv|new[31]	coref	8-4[40_0]
7-54	607-613	growth	abstract|abstract[31]	new|new[31]	coref	18-22[143_0]
7-55	614-622	kinetics	abstract[31]	new[31]	_	_
7-56	623-624	,	_	_	_	_
7-57	625-628	the	quantity[32]	new[32]	appos	7-60[34_32]
7-58	629-640	temperature	quantity[32]	new[32]	_	_
7-59	641-642	(	_	_	_	_
7-60	643-656	refrigeration	substance|quantity[34]	new|giv[34]	_	_
7-61	657-659	or	quantity[34]	giv[34]	_	_
7-62	660-665	abuse	quantity[34]|event	giv[34]|new	coref	10-28
7-63	666-667	)	_	_	_	_
7-64	668-669	,	_	_	_	_
7-65	670-673	and	_	_	_	_
7-66	674-677	the	abstract[36]	new[36]	coref	7-70[0_36]
7-67	678-686	targeted	abstract[36]	new[36]	_	_
7-68	687-696	pathogens	abstract[36]	new[36]	_	_
7-69	697-700	are	_	_	_	_
7-70	701-708	factors	abstract	giv	coref	15-31[121_0]
7-71	709-711	to	_	_	_	_
7-72	712-714	be	_	_	_	_
7-73	715-720	taken	_	_	_	_
7-74	721-725	into	_	_	_	_
7-75	726-733	account	abstract	new	_	_
7-76	734-735	.	_	_	_	_

#Text=The use of LAB for biopreservation comes back to the 1950s for preventing the production of botulinum toxin ; Clostridium botulinum is unable to grow at pH < 4.6 , so LAB is added to the food for acid production after the use of a fermentable carbohydrate also added to it and , consequently , the pH decreases .
8-1	736-739	The	abstract[39]	new[39]	_	_
8-2	740-743	use	abstract[39]	new[39]	_	_
8-3	744-746	of	abstract[39]	new[39]	_	_
8-4	747-750	LAB	abstract[39]|object[40]	new[39]|giv[40]	coref	8-32[0_40]
8-5	751-754	for	abstract[39]|object[40]	new[39]|giv[40]	_	_
8-6	755-770	biopreservation	abstract[39]|object[40]|substance	new[39]|giv[40]|giv	_	_
8-7	771-776	comes	_	_	_	_
8-8	777-781	back	_	_	_	_
8-9	782-784	to	_	_	_	_
8-10	785-788	the	time[42]	new[42]	_	_
8-11	789-794	1950s	time[42]	new[42]	_	_
8-12	795-798	for	_	_	_	_
8-13	799-809	preventing	_	_	_	_
8-14	810-813	the	abstract[43]	new[43]	coref	8-39[52_43]
8-15	814-824	production	abstract[43]	new[43]	_	_
8-16	825-827	of	abstract[43]	new[43]	_	_
8-17	828-837	botulinum	abstract[43]|substance|object[45]	new[43]|new|new[45]	coref|coref	8-20[46_0]|8-20[46_0]
8-18	838-843	toxin	abstract[43]|object[45]	new[43]|new[45]	_	_
8-19	844-845	;	_	_	_	_
8-20	846-857	Clostridium	substance[46]	giv[46]	_	_
8-21	858-867	botulinum	substance[46]	giv[46]	_	_
8-22	868-870	is	_	_	_	_
8-23	871-877	unable	_	_	_	_
8-24	878-880	to	_	_	_	_
8-25	881-885	grow	abstract|abstract	new|new	coref|coref|none|none|coref|coref|none|none	20-25[160_0]|21-4[164_0]|8-25[0_160]|8-25[0_164]|20-25[160_0]|21-4[164_0]|8-25[0_160]|8-25[0_164]
8-26	886-888	at	_	_	_	_
8-27	889-891	pH	abstract	giv	coref	8-56[57_0]
8-28	892-893	<	_	_	_	_
8-29	894-897	4.6	quantity	new	_	_
8-30	898-899	,	_	_	_	_
8-31	900-902	so	_	_	_	_
8-32	903-906	LAB	object	giv	coref	14-18[109_0]
8-33	907-909	is	_	_	_	_
8-34	910-915	added	_	_	_	_
8-35	916-918	to	_	_	_	_
8-36	919-922	the	substance[50]	giv[50]	coref	13-38[98_50]
8-37	923-927	food	substance[50]	giv[50]	_	_
8-38	928-931	for	substance[50]	giv[50]	_	_
8-39	932-936	acid	substance[50]|substance|abstract[52]	giv[50]|giv|giv[52]	coref|coref	9-12|9-12
8-40	937-947	production	substance[50]|abstract[52]	giv[50]|giv[52]	_	_
8-41	948-953	after	_	_	_	_
8-42	954-957	the	abstract[53]	new[53]	ana	8-51[0_53]
8-43	958-961	use	abstract[53]	new[53]	_	_
8-44	962-964	of	abstract[53]	new[53]	_	_
8-45	965-966	a	abstract[53]|substance[55]	new[53]|giv[55]	_	_
8-46	967-978	fermentable	abstract[53]|abstract|substance[55]	new[53]|new|giv[55]	_	_
8-47	979-991	carbohydrate	abstract[53]|substance[55]	new[53]|giv[55]	_	_
8-48	992-996	also	_	_	_	_
8-49	997-1002	added	_	_	_	_
8-50	1003-1005	to	_	_	_	_
8-51	1006-1008	it	abstract	giv	_	_
8-52	1009-1012	and	_	_	_	_
8-53	1013-1014	,	_	_	_	_
8-54	1015-1027	consequently	_	_	_	_
8-55	1028-1029	,	_	_	_	_
8-56	1030-1033	the	abstract[57]	giv[57]	_	_
8-57	1034-1036	pH	abstract[57]	giv[57]	_	_
8-58	1037-1046	decreases	_	_	_	_
8-59	1047-1048	.	_	_	_	_

#Text=Hutton and Chehak described the “ Wisconsin process ” ( lactic acid starter culture combined with sucrose ) as a similar method to be applied in bacon with a reduced content of nitrite .
9-1	1049-1055	Hutton	person	new	_	_
9-2	1056-1059	and	_	_	_	_
9-3	1060-1066	Chehak	person	new	_	_
9-4	1067-1076	described	_	_	_	_
9-5	1077-1080	the	abstract[61]	new[61]	appos	9-11[65_61]
9-6	1081-1082	“	abstract[61]	new[61]	_	_
9-7	1083-1092	Wisconsin	place|abstract[61]	new|new[61]	_	_
9-8	1093-1100	process	abstract[61]	new[61]	_	_
9-9	1101-1102	”	abstract[61]	new[61]	_	_
9-10	1103-1104	(	_	_	_	_
9-11	1105-1111	lactic	abstract|abstract[65]	new|giv[65]	coref|coref	13-2|13-2
9-12	1112-1116	acid	substance|abstract[65]	giv|giv[65]	coref	10-38[81_0]
9-13	1117-1124	starter	abstract|abstract[65]	new|giv[65]	coref	25-5
9-14	1125-1132	culture	abstract[65]	giv[65]	_	_
9-15	1133-1141	combined	_	_	_	_
9-16	1142-1146	with	_	_	_	_
9-17	1147-1154	sucrose	substance	new	_	_
9-18	1155-1156	)	_	_	_	_
9-19	1157-1159	as	_	_	_	_
9-20	1160-1161	a	_	_	_	_
9-21	1162-1169	similar	_	_	_	_
9-22	1170-1176	method	_	_	_	_
9-23	1177-1179	to	_	_	_	_
9-24	1180-1182	be	_	_	_	_
9-25	1183-1190	applied	_	_	_	_
9-26	1191-1193	in	_	_	_	_
9-27	1194-1199	bacon	substance	new	_	_
9-28	1200-1204	with	_	_	_	_
9-29	1205-1206	a	substance[68]	new[68]	_	_
9-30	1207-1214	reduced	substance[68]	new[68]	_	_
9-31	1215-1222	content	substance[68]	new[68]	_	_
9-32	1223-1225	of	substance[68]	new[68]	_	_
9-33	1226-1233	nitrite	substance[68]|substance	new[68]|new	_	_
9-34	1234-1235	.	_	_	_	_

#Text=These authors also found a similar effect with the combination of Pediococcus acidilactici plus dextrose in chicken salad ; it was interesting to report that conditions of abuse temperature were the most effective for the production of acid by P. acidilactici after the use of dextrose .
10-1	1236-1241	These	person[70]	new[70]	_	_
10-2	1242-1249	authors	person[70]	new[70]	_	_
10-3	1250-1254	also	_	_	_	_
10-4	1255-1260	found	_	_	_	_
10-5	1261-1262	a	abstract[71]	new[71]	_	_
10-6	1263-1270	similar	abstract[71]	new[71]	_	_
10-7	1271-1277	effect	abstract[71]	new[71]	_	_
10-8	1278-1282	with	abstract[71]	new[71]	_	_
10-9	1283-1286	the	abstract[71]|abstract[72]	new[71]|new[72]	ana	10-20[0_72]
10-10	1287-1298	combination	abstract[71]|abstract[72]	new[71]|new[72]	_	_
10-11	1299-1301	of	abstract[71]|abstract[72]	new[71]|new[72]	_	_
10-12	1302-1313	Pediococcus	abstract[71]|abstract[72]	new[71]|new[72]	_	_
10-13	1314-1326	acidilactici	abstract[71]|abstract[72]	new[71]|new[72]	_	_
10-14	1327-1331	plus	abstract[71]|abstract[72]	new[71]|new[72]	_	_
10-15	1332-1340	dextrose	abstract[71]|abstract[72]|substance[73]	new[71]|new[72]|new[73]	coref	10-46[0_73]
10-16	1341-1343	in	abstract[71]|abstract[72]|substance[73]	new[71]|new[72]|new[73]	_	_
10-17	1344-1351	chicken	abstract[71]|abstract[72]|substance[73]|animal|substance[75]	new[71]|new[72]|new[73]|new|new[75]	coref|coref	21-16[0_75]|21-16[0_75]
10-18	1352-1357	salad	abstract[71]|abstract[72]|substance[73]|substance[75]	new[71]|new[72]|new[73]|new[75]	_	_
10-19	1358-1359	;	_	_	_	_
10-20	1360-1362	it	abstract	giv	_	_
10-21	1363-1366	was	_	_	_	_
10-22	1367-1378	interesting	_	_	_	_
10-23	1379-1381	to	_	_	_	_
10-24	1382-1388	report	_	_	_	_
10-25	1389-1393	that	_	_	_	_
10-26	1394-1404	conditions	abstract[77]	giv[77]	_	_
10-27	1405-1407	of	abstract[77]	giv[77]	_	_
10-28	1408-1413	abuse	abstract[77]|event|abstract[79]	giv[77]|giv|new[79]	_	_
10-29	1414-1425	temperature	abstract[77]|abstract[79]	giv[77]|new[79]	_	_
10-30	1426-1430	were	_	_	_	_
10-31	1431-1434	the	_	_	_	_
10-32	1435-1439	most	_	_	_	_
10-33	1440-1449	effective	_	_	_	_
10-34	1450-1453	for	_	_	_	_
10-35	1454-1457	the	event[80]	new[80]	_	_
10-36	1458-1468	production	event[80]	new[80]	_	_
10-37	1469-1471	of	event[80]	new[80]	_	_
10-38	1472-1476	acid	event[80]|substance[81]	new[80]|giv[81]	_	_
10-39	1477-1479	by	event[80]|substance[81]	new[80]|giv[81]	_	_
10-40	1480-1482	P.	event[80]|substance[81]|place[82]	new[80]|giv[81]|new[82]	_	_
10-41	1483-1495	acidilactici	event[80]|substance[81]|place[82]	new[80]|giv[81]|new[82]	_	_
10-42	1496-1501	after	_	_	_	_
10-43	1502-1505	the	event[83]	new[83]	_	_
10-44	1506-1509	use	event[83]	new[83]	_	_
10-45	1510-1512	of	event[83]	new[83]	_	_
10-46	1513-1521	dextrose	event[83]|substance	new[83]|giv	_	_
10-47	1522-1523	.	_	_	_	_

#Text=4.2 .
11-1	1524-1527	4.2	abstract	new	_	_
11-2	1528-1529	.	_	_	_	_

#Text=Bacteriocins
12-1	1530-1542	Bacteriocins	abstract	new	_	_

#Text=Some lactic acid bacteria produce ribosomally synthesized peptides , called bacteriocins , with antimicrobial capacity that are not lethal to the host ; these proteins inhibit both pathogenic and spoilage bacteria without changing the physicochemical characteristics of the food , that is , the inhibition is not exerted by acidification , protein denaturation , or other processes .
13-1	1543-1547	Some	substance[88]	giv[88]	coref	13-30[96_88]
13-2	1548-1554	lactic	abstract|substance[88]	giv|giv[88]	_	_
13-3	1555-1559	acid	substance[88]	giv[88]	_	_
13-4	1560-1568	bacteria	substance[88]	giv[88]	_	_
13-5	1569-1576	produce	_	_	_	_
13-6	1577-1588	ribosomally	object[89]	new[89]	_	_
13-7	1589-1600	synthesized	object[89]	new[89]	_	_
13-8	1601-1609	peptides	object[89]	new[89]	_	_
13-9	1610-1611	,	_	_	_	_
13-10	1612-1618	called	_	_	_	_
13-11	1619-1631	bacteriocins	substance[90]	new[90]	coref	14-4[105_90]
13-12	1632-1633	,	substance[90]	new[90]	_	_
13-13	1634-1638	with	substance[90]	new[90]	_	_
13-14	1639-1652	antimicrobial	substance[90]|abstract[91]	new[90]|new[91]	coref	25-9[206_91]
13-15	1653-1661	capacity	substance[90]|abstract[91]	new[90]|new[91]	_	_
13-16	1662-1666	that	_	_	_	_
13-17	1667-1670	are	_	_	_	_
13-18	1671-1674	not	_	_	_	_
13-19	1675-1681	lethal	_	_	_	_
13-20	1682-1684	to	_	_	_	_
13-21	1685-1688	the	person[92]	new[92]	_	_
13-22	1689-1693	host	person[92]	new[92]	_	_
13-23	1694-1695	;	_	_	_	_
13-24	1696-1701	these	object[93]	new[93]	_	_
13-25	1702-1710	proteins	object[93]	new[93]	_	_
13-26	1711-1718	inhibit	_	_	_	_
13-27	1719-1723	both	abstract[94]	new[94]	coref	18-25[144_94]
13-28	1724-1734	pathogenic	abstract[94]	new[94]	_	_
13-29	1735-1738	and	_	_	_	_
13-30	1739-1747	spoilage	abstract|substance[96]	new|giv[96]	coref|coref	16-1[122_96]|16-1[122_96]
13-31	1748-1756	bacteria	substance[96]	giv[96]	_	_
13-32	1757-1764	without	_	_	_	_
13-33	1765-1773	changing	_	_	_	_
13-34	1774-1777	the	abstract[97]	new[97]	_	_
13-35	1778-1793	physicochemical	abstract[97]	new[97]	_	_
13-36	1794-1809	characteristics	abstract[97]	new[97]	_	_
13-37	1810-1812	of	abstract[97]	new[97]	_	_
13-38	1813-1816	the	abstract[97]|substance[98]	new[97]|giv[98]	coref	15-14[0_98]
13-39	1817-1821	food	abstract[97]|substance[98]	new[97]|giv[98]	_	_
13-40	1822-1823	,	_	_	_	_
13-41	1824-1828	that	_	_	_	_
13-42	1829-1831	is	_	_	_	_
13-43	1832-1833	,	_	_	_	_
13-44	1834-1837	the	abstract[99]	new[99]	_	_
13-45	1838-1848	inhibition	abstract[99]	new[99]	_	_
13-46	1849-1851	is	_	_	_	_
13-47	1852-1855	not	_	_	_	_
13-48	1856-1863	exerted	_	_	_	_
13-49	1864-1866	by	_	_	_	_
13-50	1867-1880	acidification	substance	giv	_	_
13-51	1881-1882	,	_	_	_	_
13-52	1883-1890	protein	substance|abstract[102]	new|new[102]	_	_
13-53	1891-1903	denaturation	abstract[102]	new[102]	_	_
13-54	1904-1905	,	_	_	_	_
13-55	1906-1908	or	_	_	_	_
13-56	1909-1914	other	abstract[103]	new[103]	_	_
13-57	1915-1924	processes	abstract[103]	new[103]	_	_
13-58	1925-1926	.	_	_	_	_

#Text=The interest in LAB-produced bacteriocins has grown dramatically because of their antimicrobial capacities and the use of LAB as starter cultures .
14-1	1927-1930	The	abstract[104]	new[104]	_	_
14-2	1931-1939	interest	abstract[104]	new[104]	_	_
14-3	1940-1942	in	abstract[104]	new[104]	_	_
14-4	1943-1955	LAB-produced	abstract[104]|substance[105]	new[104]|giv[105]	ana	14-11[0_105]
14-5	1956-1968	bacteriocins	abstract[104]|substance[105]	new[104]|giv[105]	_	_
14-6	1969-1972	has	_	_	_	_
14-7	1973-1978	grown	_	_	_	_
14-8	1979-1991	dramatically	_	_	_	_
14-9	1992-1999	because	_	_	_	_
14-10	2000-2002	of	_	_	_	_
14-11	2003-2008	their	substance|abstract[107]	giv|new[107]	coref|coref	15-4|15-4
14-12	2009-2022	antimicrobial	abstract[107]	new[107]	_	_
14-13	2023-2033	capacities	abstract[107]	new[107]	_	_
14-14	2034-2037	and	_	_	_	_
14-15	2038-2041	the	abstract[108]	new[108]	_	_
14-16	2042-2045	use	abstract[108]	new[108]	_	_
14-17	2046-2048	of	abstract[108]	new[108]	_	_
14-18	2049-2052	LAB	abstract[108]|object[109]	new[108]|giv[109]	coref	15-6[113_109]
14-19	2053-2055	as	abstract[108]|object[109]	new[108]|giv[109]	_	_
14-20	2056-2063	starter	abstract[108]|object[109]	new[108]|giv[109]	_	_
14-21	2064-2072	cultures	abstract[108]|object[109]	new[108]|giv[109]	_	_
14-22	2073-2074	.	_	_	_	_

#Text=The use of bacteriocins or bacteriocinogenic LAB or both is important to the food industry because of the demand for natural products by consumers that are also increasing concern about foodborne pathogens .
15-1	2075-2078	The	abstract[110]	new[110]	_	_
15-2	2079-2082	use	abstract[110]	new[110]	_	_
15-3	2083-2085	of	abstract[110]	new[110]	_	_
15-4	2086-2098	bacteriocins	abstract[110]|substance	new[110]|giv	coref	16-6[123_0]
15-5	2099-2101	or	abstract[110]	new[110]	_	_
15-6	2102-2119	bacteriocinogenic	abstract[110]|abstract|object[113]	new[110]|new|giv[113]	_	_
15-7	2120-2123	LAB	abstract[110]|object[113]	new[110]|giv[113]	_	_
15-8	2124-2126	or	abstract[110]	new[110]	_	_
15-9	2127-2131	both	abstract[110]	new[110]	_	_
15-10	2132-2134	is	_	_	_	_
15-11	2135-2144	important	_	_	_	_
15-12	2145-2147	to	_	_	_	_
15-13	2148-2151	the	abstract[115]	new[115]	_	_
15-14	2152-2156	food	substance|abstract[115]	giv|new[115]	coref	20-13
15-15	2157-2165	industry	abstract[115]	new[115]	_	_
15-16	2166-2173	because	_	_	_	_
15-17	2174-2176	of	_	_	_	_
15-18	2177-2180	the	abstract[116]	new[116]	_	_
15-19	2181-2187	demand	abstract[116]	new[116]	_	_
15-20	2188-2191	for	abstract[116]	new[116]	_	_
15-21	2192-2199	natural	abstract[116]|abstract[117]	new[116]|new[117]	_	_
15-22	2200-2208	products	abstract[116]|abstract[117]	new[116]|new[117]	_	_
15-23	2209-2211	by	abstract[116]|abstract[117]	new[116]|new[117]	_	_
15-24	2212-2221	consumers	abstract[116]|abstract[117]|person	new[116]|new[117]|new	_	_
15-25	2222-2226	that	_	_	_	_
15-26	2227-2230	are	_	_	_	_
15-27	2231-2235	also	_	_	_	_
15-28	2236-2246	increasing	_	_	_	_
15-29	2247-2254	concern	abstract	new	_	_
15-30	2255-2260	about	_	_	_	_
15-31	2261-2270	foodborne	abstract|abstract[121]	new|giv[121]	coref|coref	24-11|24-11
15-32	2271-2280	pathogens	abstract[121]	giv[121]	_	_
15-33	2281-2282	.	_	_	_	_

#Text=Gram-positive bacteria are inhibited by most bacteriocins .
16-1	2283-2296	Gram-positive	substance[122]	giv[122]	coref	17-1[124_122]
16-2	2297-2305	bacteria	substance[122]	giv[122]	_	_
16-3	2306-2309	are	_	_	_	_
16-4	2310-2319	inhibited	_	_	_	_
16-5	2320-2322	by	_	_	_	_
16-6	2323-2327	most	substance[123]	giv[123]	coref	17-8[125_123]
16-7	2328-2340	bacteriocins	substance[123]	giv[123]	_	_
16-8	2341-2342	.	_	_	_	_

#Text=Gram-negative bacteria can be increasingly sensitive to bacteriocins after the use of chelating agents or hydrostatic pressure ; these techniques can also be synergic enhancing the action of bacteriocins against Gram-positive bacteria , or even with the use of nanoparticles or nanovesicles .
17-1	2343-2356	Gram-negative	substance[124]	giv[124]	coref	17-31[133_124]
17-2	2357-2365	bacteria	substance[124]	giv[124]	_	_
17-3	2366-2369	can	_	_	_	_
17-4	2370-2372	be	_	_	_	_
17-5	2373-2385	increasingly	_	_	_	_
17-6	2386-2395	sensitive	_	_	_	_
17-7	2396-2398	to	_	_	_	_
17-8	2399-2411	bacteriocins	substance[125]	giv[125]	coref	17-29[132_125]
17-9	2412-2417	after	substance[125]	giv[125]	_	_
17-10	2418-2421	the	substance[125]|abstract[126]	giv[125]|new[126]	_	_
17-11	2422-2425	use	substance[125]|abstract[126]	giv[125]|new[126]	_	_
17-12	2426-2428	of	substance[125]|abstract[126]	giv[125]|new[126]	_	_
17-13	2429-2438	chelating	substance[125]|abstract[126]|person|substance[128]	giv[125]|new[126]|new|new[128]	_	_
17-14	2439-2445	agents	substance[125]|abstract[126]|substance[128]	giv[125]|new[126]|new[128]	_	_
17-15	2446-2448	or	substance[125]|abstract[126]	giv[125]|new[126]	_	_
17-16	2449-2460	hydrostatic	substance[125]|abstract[126]|abstract[129]	giv[125]|new[126]|new[129]	_	_
17-17	2461-2469	pressure	substance[125]|abstract[126]|abstract[129]	giv[125]|new[126]|new[129]	_	_
17-18	2470-2471	;	_	_	_	_
17-19	2472-2477	these	abstract[130]	new[130]	_	_
17-20	2478-2488	techniques	abstract[130]	new[130]	_	_
17-21	2489-2492	can	_	_	_	_
17-22	2493-2497	also	_	_	_	_
17-23	2498-2500	be	_	_	_	_
17-24	2501-2509	synergic	_	_	_	_
17-25	2510-2519	enhancing	_	_	_	_
17-26	2520-2523	the	abstract[131]	new[131]	_	_
17-27	2524-2530	action	abstract[131]	new[131]	_	_
17-28	2531-2533	of	abstract[131]	new[131]	_	_
17-29	2534-2546	bacteriocins	abstract[131]|substance[132]	new[131]|giv[132]	coref	18-1[0_132]
17-30	2547-2554	against	abstract[131]|substance[132]	new[131]|giv[132]	_	_
17-31	2555-2568	Gram-positive	abstract[131]|substance[132]|substance[133]	new[131]|giv[132]|giv[133]	coref	18-28[145_133]
17-32	2569-2577	bacteria	abstract[131]|substance[132]|substance[133]	new[131]|giv[132]|giv[133]	_	_
17-33	2578-2579	,	_	_	_	_
17-34	2580-2582	or	_	_	_	_
17-35	2583-2587	even	abstract[134]	new[134]	ana	18-12[0_134]
17-36	2588-2592	with	abstract[134]	new[134]	_	_
17-37	2593-2596	the	abstract[134]	new[134]	_	_
17-38	2597-2600	use	abstract[134]	new[134]	_	_
17-39	2601-2603	of	abstract[134]	new[134]	_	_
17-40	2604-2617	nanoparticles	abstract[134]|object	new[134]|new	_	_
17-41	2618-2620	or	abstract[134]	new[134]	_	_
17-42	2621-2633	nanovesicles	abstract[134]|object	new[134]|new	_	_
17-43	2634-2635	.	_	_	_	_

#Text=Bacteriocins can be used in different ways in foods : ( i ) They can be directly added to foods inhibiting the growth of both pathogenic and spoilage bacteria ; nisin is the only bacteriocin commercially available .
18-1	2636-2648	Bacteriocins	substance	giv	_	_
18-2	2649-2652	can	_	_	_	_
18-3	2653-2655	be	_	_	_	_
18-4	2656-2660	used	_	_	_	_
18-5	2661-2663	in	_	_	_	_
18-6	2664-2673	different	abstract[138]	new[138]	ana	18-14[0_138]
18-7	2674-2678	ways	abstract[138]	new[138]	_	_
18-8	2679-2681	in	abstract[138]	new[138]	_	_
18-9	2682-2687	foods	abstract[138]|substance	new[138]|giv	coref	18-20
18-10	2688-2689	:	_	_	_	_
18-11	2690-2691	(	_	_	_	_
18-12	2692-2693	i	abstract	giv	_	_
18-13	2694-2695	)	_	_	_	_
18-14	2696-2700	They	abstract	giv	_	_
18-15	2701-2704	can	_	_	_	_
18-16	2705-2707	be	_	_	_	_
18-17	2708-2716	directly	_	_	_	_
18-18	2717-2722	added	_	_	_	_
18-19	2723-2725	to	_	_	_	_
18-20	2726-2731	foods	substance	giv	coref	19-9[151_0]
18-21	2732-2742	inhibiting	_	_	_	_
18-22	2743-2746	the	abstract[143]	giv[143]	ana	20-1[0_143]
18-23	2747-2753	growth	abstract[143]	giv[143]	_	_
18-24	2754-2756	of	abstract[143]	giv[143]	_	_
18-25	2757-2761	both	abstract[143]|abstract[144]	giv[143]|giv[144]	_	_
18-26	2762-2772	pathogenic	abstract[143]|abstract[144]	giv[143]|giv[144]	_	_
18-27	2773-2776	and	abstract[143]	giv[143]	_	_
18-28	2777-2785	spoilage	abstract[143]|substance[145]	giv[143]|giv[145]	coref	22-11[177_145]
18-29	2786-2794	bacteria	abstract[143]|substance[145]	giv[143]|giv[145]	_	_
18-30	2795-2796	;	_	_	_	_
18-31	2797-2802	nisin	substance	new	coref	18-33[147_0]
18-32	2803-2805	is	_	_	_	_
18-33	2806-2809	the	substance[147]	giv[147]	coref	19-1[0_147]
18-34	2810-2814	only	substance[147]	giv[147]	_	_
18-35	2815-2826	bacteriocin	substance[147]	giv[147]	_	_
18-36	2827-2839	commercially	substance[147]	giv[147]	_	_
18-37	2840-2849	available	substance[147]	giv[147]	_	_
18-38	2850-2851	.	_	_	_	_

#Text=Nisin is added to milk , cheese , canned foods , mayonnaise , and other foods .
19-1	2852-2857	Nisin	substance	giv	_	_
19-2	2858-2860	is	_	_	_	_
19-3	2861-2866	added	_	_	_	_
19-4	2867-2869	to	_	_	_	_
19-5	2870-2874	milk	substance	new	_	_
19-6	2875-2876	,	_	_	_	_
19-7	2877-2883	cheese	substance	new	coref	21-21
19-8	2884-2885	,	_	_	_	_
19-9	2886-2892	canned	substance[151]	giv[151]	coref	19-15[153_151]
19-10	2893-2898	foods	substance[151]	giv[151]	_	_
19-11	2899-2900	,	_	_	_	_
19-12	2901-2911	mayonnaise	substance	new	_	_
19-13	2912-2913	,	_	_	_	_
19-14	2914-2917	and	_	_	_	_
19-15	2918-2923	other	substance[153]	giv[153]	coref	22-25[180_153]
19-16	2924-2929	foods	substance[153]	giv[153]	_	_
19-17	2930-2931	.	_	_	_	_

#Text=It is considered as a Generally Recognized as Safe ( GRAS ) food preservative , and once it is absorbed onto surfaces it inhibits the growth of Listeria spp. and prevents the formation of biofilms .
20-1	2932-2934	It	abstract	giv	ana	20-18
20-2	2935-2937	is	_	_	_	_
20-3	2938-2948	considered	_	_	_	_
20-4	2949-2951	as	_	_	_	_
20-5	2952-2953	a	_	_	_	_
20-6	2954-2963	Generally	_	_	_	_
20-7	2964-2974	Recognized	_	_	_	_
20-8	2975-2977	as	_	_	_	_
20-9	2978-2982	Safe	_	_	_	_
20-10	2983-2984	(	_	_	_	_
20-11	2985-2989	GRAS	person	new	_	_
20-12	2990-2991	)	_	_	_	_
20-13	2992-2996	food	substance	giv	coref	22-37
20-14	2997-3009	preservative	_	_	_	_
20-15	3010-3011	,	_	_	_	_
20-16	3012-3015	and	_	_	_	_
20-17	3016-3020	once	_	_	_	_
20-18	3021-3023	it	abstract	giv	ana	20-23
20-19	3024-3026	is	_	_	_	_
20-20	3027-3035	absorbed	_	_	_	_
20-21	3036-3040	onto	_	_	_	_
20-22	3041-3049	surfaces	object	new	ana	21-10
20-23	3050-3052	it	abstract	giv	_	_
20-24	3053-3061	inhibits	_	_	_	_
20-25	3062-3065	the	abstract[160]	new[160]	_	_
20-26	3066-3072	growth	abstract[160]	new[160]	_	_
20-27	3073-3075	of	abstract[160]	new[160]	_	_
20-28	3076-3084	Listeria	abstract[160]	new[160]	_	_
20-29	3085-3089	spp.	abstract[160]	new[160]	_	_
20-30	3090-3093	and	_	_	_	_
20-31	3094-3102	prevents	_	_	_	_
20-32	3103-3106	the	event[161]	new[161]	_	_
20-33	3107-3116	formation	event[161]	new[161]	_	_
20-34	3117-3119	of	event[161]	new[161]	_	_
20-35	3120-3128	biofilms	event[161]|substance	new[161]|new	_	_
20-36	3129-3130	.	_	_	_	_

#Text=Pediocins also inhibit the growth of L. monocytogenes and they are used in salads and salad dressings , cream , cheese and meats .
21-1	3131-3140	Pediocins	substance	new	_	_
21-2	3141-3145	also	_	_	_	_
21-3	3146-3153	inhibit	_	_	_	_
21-4	3154-3157	the	abstract[164]	new[164]	_	_
21-5	3158-3164	growth	abstract[164]	new[164]	_	_
21-6	3165-3167	of	abstract[164]	new[164]	_	_
21-7	3168-3170	L.	abstract[164]|person|place[166]	new[164]|new|new[166]	_	_
21-8	3171-3184	monocytogenes	abstract[164]|place[166]	new[164]|new[166]	_	_
21-9	3185-3188	and	_	_	_	_
21-10	3189-3193	they	object	giv	_	_
21-11	3194-3197	are	_	_	_	_
21-12	3198-3202	used	_	_	_	_
21-13	3203-3205	in	_	_	_	_
21-14	3206-3212	salads	object|abstract[169]	new|new[169]	ana|ana	22-29[0_169]|22-29[0_169]
21-15	3213-3216	and	abstract[169]	new[169]	_	_
21-16	3217-3222	salad	abstract[169]|substance|object[171]	new[169]|giv|new[171]	_	_
21-17	3223-3232	dressings	abstract[169]|object[171]	new[169]|new[171]	_	_
21-18	3233-3234	,	abstract[169]	new[169]	_	_
21-19	3235-3240	cream	abstract[169]|substance	new[169]|new	_	_
21-20	3241-3242	,	abstract[169]	new[169]	_	_
21-21	3243-3249	cheese	abstract[169]|substance	new[169]|giv	_	_
21-22	3250-3253	and	abstract[169]	new[169]	_	_
21-23	3254-3259	meats	abstract[169]|substance	new[169]|new	_	_
21-24	3260-3261	.	_	_	_	_

#Text=Reuterin is secreted by Lactobacillus reuteri and possess activity against Gram-positive and -negative pathogenic bacteria . ( ii ) To add bacteriocin-producing bacteria to non-fermented foods or use them as starter cultures for the improvement of food safety .
22-1	3262-3270	Reuterin	substance	new	_	_
22-2	3271-3273	is	_	_	_	_
22-3	3274-3282	secreted	_	_	_	_
22-4	3283-3285	by	_	_	_	_
22-5	3286-3299	Lactobacillus	_	_	_	_
22-6	3300-3307	reuteri	_	_	_	_
22-7	3308-3311	and	_	_	_	_
22-8	3312-3319	possess	_	_	_	_
22-9	3320-3328	activity	abstract[176]	new[176]	_	_
22-10	3329-3336	against	abstract[176]	new[176]	_	_
22-11	3337-3350	Gram-positive	abstract[176]|substance[177]	new[176]|giv[177]	appos	22-18[0_177]
22-12	3351-3354	and	abstract[176]|substance[177]	new[176]|giv[177]	_	_
22-13	3355-3364	-negative	abstract[176]|substance[177]	new[176]|giv[177]	_	_
22-14	3365-3375	pathogenic	abstract[176]|substance[177]	new[176]|giv[177]	_	_
22-15	3376-3384	bacteria	abstract[176]|substance[177]	new[176]|giv[177]	_	_
22-16	3385-3386	.	_	_	_	_
22-17	3387-3388	(	_	_	_	_
22-18	3389-3391	ii	substance	giv	coref	22-22[179_0]
22-19	3392-3393	)	_	_	_	_
22-20	3394-3396	To	_	_	_	_
22-21	3397-3400	add	_	_	_	_
22-22	3401-3422	bacteriocin-producing	substance[179]	giv[179]	coref	24-22[0_179]
22-23	3423-3431	bacteria	substance[179]	giv[179]	_	_
22-24	3432-3434	to	substance[179]	giv[179]	_	_
22-25	3435-3448	non-fermented	substance[179]|substance[180]	giv[179]|giv[180]	_	_
22-26	3449-3454	foods	substance[179]|substance[180]	giv[179]|giv[180]	_	_
22-27	3455-3457	or	_	_	_	_
22-28	3458-3461	use	_	_	_	_
22-29	3462-3466	them	abstract	giv	_	_
22-30	3467-3469	as	_	_	_	_
22-31	3470-3477	starter	_	_	_	_
22-32	3478-3486	cultures	_	_	_	_
22-33	3487-3490	for	_	_	_	_
22-34	3491-3494	the	abstract[182]	new[182]	_	_
22-35	3495-3506	improvement	abstract[182]	new[182]	_	_
22-36	3507-3509	of	abstract[182]	new[182]	_	_
22-37	3510-3514	food	abstract[182]|substance|abstract[184]	new[182]|giv|new[184]	_	_
22-38	3515-3521	safety	abstract[182]|abstract[184]	new[182]|new[184]	_	_
22-39	3522-3523	.	_	_	_	_

#Text=For a fine description see Montville and Chikindas .
23-1	3524-3527	For	_	_	_	_
23-2	3528-3529	a	abstract[185]	new[185]	_	_
23-3	3530-3534	fine	abstract[185]	new[185]	_	_
23-4	3535-3546	description	abstract[185]	new[185]	_	_
23-5	3547-3550	see	_	_	_	_
23-6	3551-3560	Montville	person	new	_	_
23-7	3561-3564	and	_	_	_	_
23-8	3565-3574	Chikindas	place	new	_	_
23-9	3575-3576	.	_	_	_	_

#Text=Natamycin is produced by fermentation using Streptomyces spp. acting against foodborne moulds and yeasts ; however , it is inactive against bacteria and viruses . ( iii ) A third way is to use bacteriocin-producing bacteria as starter cultures to direct the fermentation .
24-1	3577-3586	Natamycin	substance	new	_	_
24-2	3587-3589	is	_	_	_	_
24-3	3590-3598	produced	_	_	_	_
24-4	3599-3601	by	_	_	_	_
24-5	3602-3614	fermentation	substance	new	ana	24-18
24-6	3615-3620	using	_	_	_	_
24-7	3621-3633	Streptomyces	abstract|object[191]	new|new[191]	_	_
24-8	3634-3638	spp.	object[191]	new[191]	_	_
24-9	3639-3645	acting	_	_	_	_
24-10	3646-3653	against	_	_	_	_
24-11	3654-3663	foodborne	place|abstract[193]	giv|new[193]	_	_
24-12	3664-3670	moulds	abstract[193]	new[193]	_	_
24-13	3671-3674	and	_	_	_	_
24-14	3675-3681	yeasts	substance	new	_	_
24-15	3682-3683	;	_	_	_	_
24-16	3684-3691	however	_	_	_	_
24-17	3692-3693	,	_	_	_	_
24-18	3694-3696	it	substance	giv	coref	24-42[201_0]
24-19	3697-3699	is	_	_	_	_
24-20	3700-3708	inactive	_	_	_	_
24-21	3709-3716	against	_	_	_	_
24-22	3717-3725	bacteria	substance|abstract[197]	giv|giv[197]	coref|ana|coref|ana	24-35[200_0]|25-9[0_197]|24-35[200_0]|25-9[0_197]
24-23	3726-3729	and	abstract[197]	giv[197]	_	_
24-24	3730-3737	viruses	abstract[197]|place	giv[197]|new	_	_
24-25	3738-3739	.	_	_	_	_
24-26	3740-3741	(	_	_	_	_
24-27	3742-3745	iii	_	_	_	_
24-28	3746-3747	)	_	_	_	_
24-29	3748-3749	A	abstract[199]	new[199]	_	_
24-30	3750-3755	third	abstract[199]	new[199]	_	_
24-31	3756-3759	way	abstract[199]	new[199]	_	_
24-32	3760-3762	is	_	_	_	_
24-33	3763-3765	to	_	_	_	_
24-34	3766-3769	use	_	_	_	_
24-35	3770-3791	bacteriocin-producing	substance[200]	giv[200]	_	_
24-36	3792-3800	bacteria	substance[200]	giv[200]	_	_
24-37	3801-3803	as	substance[200]	giv[200]	_	_
24-38	3804-3811	starter	substance[200]	giv[200]	_	_
24-39	3812-3820	cultures	substance[200]	giv[200]	_	_
24-40	3821-3823	to	_	_	_	_
24-41	3824-3830	direct	_	_	_	_
24-42	3831-3834	the	substance[201]	giv[201]	_	_
24-43	3835-3847	fermentation	substance[201]	giv[201]	_	_
24-44	3848-3849	.	_	_	_	_

#Text=The benefits of defined starter cultures depend on their capacity to predominate over the indigenous microbiota .
25-1	3850-3853	The	abstract[202]	new[202]	_	_
25-2	3854-3862	benefits	abstract[202]	new[202]	_	_
25-3	3863-3865	of	abstract[202]	new[202]	_	_
25-4	3866-3873	defined	abstract[202]|object[204]	new[202]|new[204]	_	_
25-5	3874-3881	starter	abstract[202]|abstract|object[204]	new[202]|giv|new[204]	_	_
25-6	3882-3890	cultures	abstract[202]|object[204]	new[202]|new[204]	_	_
25-7	3891-3897	depend	_	_	_	_
25-8	3898-3900	on	_	_	_	_
25-9	3901-3906	their	abstract|abstract[206]	giv|giv[206]	_	_
25-10	3907-3915	capacity	abstract[206]	giv[206]	_	_
25-11	3916-3918	to	_	_	_	_
25-12	3919-3930	predominate	_	_	_	_
25-13	3931-3935	over	_	_	_	_
25-14	3936-3939	the	abstract[207]	new[207]	_	_
25-15	3940-3950	indigenous	abstract[207]	new[207]	_	_
25-16	3951-3961	microbiota	abstract[207]	new[207]	_	_
25-17	3962-3963	.	_	_	_	_
